PNC Financial Services Group
RKDA icon

PNC Financial Services Group’s Arcadia Biosciences RKDA Stock Holding History

PNC Financial Services Group’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$54 – 4797
2022
Q4 		$54 Buy
+5
New +$71 ﹤0.01% 4720

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PNC Financial Services Group's RKDA Position: Q1 2023 in Review

PNC Financial Services Group sold out of Arcadia Biosciences (RKDA) in Q1 2023, closing a stake of 5 shares — an estimated $54 sold.

PNC Financial Services Group first reported a position in RKDA in Q4 2022 and held it in 1 quarter. The position peaked at $54 in Q4 2022. 15 funds tracked by Wall St. Rank hold RKDA as of Q1 2023.

  • PNC Financial Services Group reported no remaining Arcadia Biosciences position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 5 Arcadia Biosciences shares in Q1 2023, an estimated $54.
  • PNC Financial Services Group first reported a position in Arcadia Biosciences in Q4 2022 and held it in 1 quarter.
  • PNC Financial Services Group's Arcadia Biosciences position peaked at $54 in Q4 2022.
  • 15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.